SEGOTX
LIVE

Serial Number

99402425

Owner

SEGO THERAPEUTICS INC

Attorney

Jonathan H. Love

Filing Date

Sep 19, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SEGOTX Trademark

Serial Number: 99402425

SEGOTX is a trademark filed by SEGO THERAPEUTICS INC on September 19, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

SEGO THERAPEUTICS INC (3 trademarks)

299 MAIN STREET, 23rd Floor
Salt Lake City, UT 84111

Entity Type: 03

Trademark Details

Filing Date

September 19, 2025

Registration Date

Not Registered

Goods & Services

Medical diagnostic services; providing medical information in the field of pharmaceutical research and clinical trials; consulting services in the field of medical testing, diagnostics, and patient-specific therapies; providing medical information in the field of oncology, namely on radiolabeled small molecule diagnostics; consulting services in the field of medical testing and diagnostic screening for cancer.

Pharmaceutical research and development; pharmaceutical research and development services in the field of small molecule cancer therapeutics; scientific and technological services, namely, research and development in the field of cancer-related pharmaceuticals and cancer-related drug discovery; research and development of pharmaceutical preparations for treating cancer; providing online non-downloadable software platforms for screening, analyzing, and identifying potential drug candidates; providing online non-downloadable software platforms for screening, analyzing, and identifying potential drug candidates for treating cancer; pharmaceutical research services; testing, inspection, research, or development of pharmaceutical preparations for cancer; providing medical and scientific research information in the field of pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer; laboratory research services relating to pharmaceuticals; laboratory research services relating to pharmaceuticals for treating cancer; consulting services in the field of pharmaceutical research and development; design and development of computer software for use in cancer-related pharmaceutical research, bioinformatics, and cancer-related drug discovery; drug discovery services; research services relating to radiolabeled small molecules for use in oncology; providing a drug discovery screening platform for identifying and characterizing small molecule candidates for the treatment of cancer.

Licensing of intellectual property

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in suppressing tumours; pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely for treating cancer; biological preparations for the treatment of cancer; small molecule pharmaceutical preparations for the treatment of cancer; small molecule pharmaceutical preparations for use in suppressing tumours; radiolabeled pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in suppressing tumours.

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 19, 2025 MAFR
NEW APPLICATION ENTERED
Sep 19, 2025 NWAP